Your Location：
Home >
Browse articles >
Effect of Modified Erchentang on Expressions of Chemokine Receptor CXCR1/2 and CXCL8 in Patients with AECOPD
Classic Prescriptions | Updated：2021-02-09
Effect of Modified Erchentang on Expressions of Chemokine Receptor CXCR1/2 and CXCL8 in Patients with AECOPD
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 24, Pages: 1-8(2019)
DOI： 10.13422/j.cnki.syfjx.20192406
Scan QR Code
Full Text(HTML)
Figs( 2 ) Tabs( 5 )
References
Publication Info
Metrics
71
Views
101
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Modified Erchentang on COPD Inflammation Based on TNF-α/TNFR1/RIPKs Pathway
Modified Erchentang Alleviates Inflammation in Chronic Obstructive Pulmonary Disease via Midkine/Notch2/Hey1 Signaling Pathway in Rats
Effect of Modified Erchentang on CC16, SP-D and HAT and HDAC in Patients at Acute Exacerbation Stage of COPD
Effect of Modified Erchentang on Hif-1 and Sirtuins 1 in Patients with COPD
Salviae Miltiorrhizae Radix et Rhizoma Extract Regulates Blood Pressure in Rat Model of Metabolic Hypertension Induced by High-sugan and High-fat Diet via TRPC3/6/NOX2/4 Sigraling Pathway
Related Author
CHEN Zhuang
LIU Gaoyang
XIE Wenying
SHANG Lizhi
HU Wenhao
LI Yaoyang
LIU Gaoyang
CHEN Zhuang
Related Institution
Henan Provincial Second People's Hospital
School of Pharmacy， Anhui University of Chinese Medicine
School of Traditional Chinese Medicine， Anhui University of Chinese Medicine
Key Laboratory of Xin'an Medicine， Ministry of Education
Anhui Collaborative Innovation Center for the Quality Enhancement of Authentic Traditional Chinese Medicinal Materials， Co-built by Provincial and Ministerial Authorities
Chat
